I understand that, and the concerns some of us have had about H5N1, for a number of years now, are hardly diminished by the emergence of this virus. But the possibilities for reassortment with H5N1 are pretty uncertain. That virus has been around for long enough that there must surely have been plenty of opportunities for it to reassort with other strains already, and while a global pandemic would increase those opportunites several fold, it remains largely a theoretical concern at this point. (The importance of the subtype distinction rears its head again when we consider the implications of a reassortment event between two viruses of different subtypes; unless one accepts recombination as a significant driving force in viral evolution, the hemagglutinin gene would have to come from one or the other, but exactly where the factors most significant in determining either virulence or pathogenicity are located on the viral genome is not known with certainty).
The possibilities that this virus may aquire antiviral resistance, either through reassortment or de novo, are also a concern, though also theoretical. If this one comes back twice as mean in the fall, and picks up resistance to oseltemivir (it's already resistant to amantadines), and if the vax flops (or if the decision is made not to attempt widespread production of a vaccine at all), then we could end up facing it essentially empty-handed. That would be scary bad.
But I always like to rembember something Winston Churchill once said: "My life has been punctuated by a long series of tragedies -- most of which never actually happened".
This virus -- in its present form -- already represents enough of a threat to deserve attention. The press is going to do with it what they will, but it's important that it receive just the right amount of attention from the epidemiological community. If they overplay it, the loss of credibility with the public could end up costing a great many lives later on. Because sooner or later, we will encounter a truly deadly strain of influenza. Is this one it? Not yet anyway. Still, even if none of the above comes to pass, the potential for, say, five times the usual number of deaths due to complications from influenza is... er... nothing to sneeze at. (Sorry).